Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-7,109
Closed -$1.21M 82
2018
Q1
$1.21M Sell
7,109
-10,922
-61% -$2M 0.18% 111
2017
Q4
$3.14M Buy
+18,031
New +$3.19M 0.2% 110
2017
Q3
Sell
-2,860
Closed -$493K 613
2017
Q2
$493K Buy
+2,860
New +$465K 0.02% 566
2016
Q4
Sell
-9,225
Closed -$1.39M 2193
2016
Q3
$1.54M Buy
+9,225
New +$1.56M 0.01% 904
2015
Q4
Sell
-32,742
Closed -$5.15M 2231
2015
Q3
$4.53M Buy
32,742
+13,686
+72% +$2.16M 0.02% 603
2015
Q2
$2.92M Buy
+19,056
New +$3.05M 0.01% 866
2014
Q3
Sell
-6,862
Closed -$896K 2552
2014
Q2
$812K Sell
6,862
-5,267
-43% -$610K ﹤0.01% 1787
2014
Q1
$1.5M Sell
12,129
-10,655
-47% -$1.29M 0.01% 1347
2013
Q4
$2.6M Sell
22,784
-71,006
-76% -$8.08M 0.01% 1181
2013
Q3
$10.5M Buy
+93,790
New +$10.2M 0.04% 440

Other funds holding AMGN

Timber Hill's AMGN Position: Q2 2018 in Review

Timber Hill sold out of Amgen (AMGN) in Q2 2018, closing a stake of 7,109 shares — an estimated $1.21M sold.

Timber Hill first reported a position in AMGN in Q3 2013 and held it in 10 quarters. The position peaked at $10.5M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Timber Hill reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 7,109 Amgen shares in Q2 2018, an estimated $1.21M.
  • Timber Hill first reported a position in Amgen in Q3 2013 and held it in 10 quarters.
  • Timber Hill's Amgen position peaked at $10.5M in Q3 2013.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.